(2E,5E)-2,5-二(2-噻吩基亚甲基)环戊酮
(2E,5E)-2,5-二(2-噻吩基亚甲基)环戊酮结构式
|
常用名 | (2E,5E)-2,5-二(2-噻吩基亚甲基)环戊酮 | 英文名 | CCT007093 |
|---|---|---|---|---|
| CAS号 | 176957-55-4 | 分子量 | 272.385 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 484.7±45.0 °C at 760 mmHg | |
| 分子式 | C15H12OS2 | 熔点 | 222-223℃ | |
| MSDS | 中文版 美版 | 闪点 | 246.9±28.7 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
|
Wip1 suppresses apoptotic cell death through direct dephosphorylation of BAX in response to γ-radiation.
Cell Death Dis. 4 , e744, (2013) Wild-type p53-induced phosphatase 1 (Wip1) is a p53-inducible serine/threonine phosphatase that switches off DNA damage checkpoint responses by the dephosphorylation of certain proteins (i.e. p38 mitogen-activated protein kinase, p53, checkpoint kinase 1, che... |
|
|
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells.
Breast Cancer Res. 12 , R41, (2010) Paclitaxel is a widely used drug in the treatment of patients with locally advanced and metastatic breast cancer. However, only a small portion of patients have a complete response to paclitaxel-based chemotherapy, and many patients are resistant. Strategies ... |
期刊文献综述：
更多...